Researchers examined “chilblain-like lesions,” which has been extensively reported in COVID-19 cases, in the blood samples and skin biopsies of 50 patients with COVID-like symptoms at Saint-Louis hospital in France in April 2020.
Researchers found high levels of Type 1 interferon, a protein that activates the body’s immune system to fight viruses, but can also cause damage. The researchers also found high levels of an antibody that can inadvertently attack the body’s own cells.
The study suggested treating the condition with local or systemic anti-inflammatory agents.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
